{"id":"W2754703762","doi":"10.1016/j.kisu.2017.07.009","title":"Action plan for optimizing the design of clinical trials in chronic kidney disease","year":2017,"lang":"en","type":"review","venue":"Kidney International Supplements","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Janssen Canada; International Society of Nephrology; Danone; Akebia Therapeutics; AbbVie; Danone Nutricia Research; AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Clinical trial; Kidney disease; Medicine; Disease; Intensive care medicine; Nephrology; Physical therapy; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006356608,0.0004266214,0.002787198,0.0003143083,0.0001128132,0.00006156656,0.0007908367,0.0002512003,0.001697063],"category_scores_gemma":[0.03418174,0.0002809485,0.001770082,0.0000833903,0.0001224541,0.000159623,0.0001761572,0.0004088258,0.00003600759],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007155405,"about_ca_system_score_gemma":0.01068325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003613336,"about_ca_topic_score_gemma":0.00000356431,"domain_scores_codex":[0.9944574,0.0009051342,0.00303898,0.0005821203,0.0006274266,0.0003889311],"domain_scores_gemma":[0.9931123,0.002506024,0.00235991,0.0007993154,0.0001808238,0.001041687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001019988,0.0006176746,0.0008265575,0.01633876,0.002649436,0.00002764954,0.00002423199,0.00001199698,0.000007267785,0.0002151112,0.5252375,0.4530239],"study_design_scores_gemma":[0.005751896,0.0001618956,0.00006287027,0.01817196,0.002948093,0.000003411409,0.000008607562,0.0008569192,0.000009473454,0.0001456672,0.9716522,0.0002270726],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000004350323,0.9652068,0.001916653,0.003369666,0.003883816,0.008575248,0.01652002,0.0000376377,0.0004858242],"genre_scores_gemma":[0.00008739323,0.9785671,0.0008523382,0.0007624415,0.002378863,0.001261759,0.01515018,0.00006618062,0.0008737413],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4527968,"threshold_uncertainty_score":0.9999643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5394688455937858,"score_gpt":0.5702939403253396,"score_spread":0.03082509473155381,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}